Insider Selling: Acadia Healthcare Company, Inc. (NASDAQ:ACHC) Director Sells 8,000 Shares of Stock
Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Get Free Report) Director Debra K. Osteen sold 8,000 shares of the stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $76.23, for a total value of $609,840.00. Following the sale, the director now directly owns 710,833 shares of the company’s stock, valued at $54,186,799.59. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Acadia Healthcare Price Performance
Shares of NASDAQ:ACHC traded down $1.38 during midday trading on Thursday, hitting $77.58. 767,570 shares of the stock were exchanged, compared to its average volume of 575,597. The stock has a market cap of $7.15 billion, a P/E ratio of -369.41, a PEG ratio of 1.99 and a beta of 1.39. The company has a current ratio of 0.81, a quick ratio of 0.81 and a debt-to-equity ratio of 0.50. Acadia Healthcare Company, Inc. has a twelve month low of $66.49 and a twelve month high of $86.37. The company has a 50 day moving average price of $73.83 and a 200-day moving average price of $73.95.
Acadia Healthcare (NASDAQ:ACHC – Get Free Report) last posted its quarterly earnings data on Thursday, November 2nd. The company reported $0.91 EPS for the quarter, topping analysts’ consensus estimates of $0.88 by $0.03. The firm had revenue of $750.33 million during the quarter, compared to analysts’ expectations of $724.27 million. Acadia Healthcare had a positive return on equity of 10.68% and a negative net margin of 0.64%. On average, research analysts forecast that Acadia Healthcare Company, Inc. will post 3.41 earnings per share for the current year.
Analyst Ratings Changes
A number of equities research analysts have commented on the company. StockNews.com assumed coverage on Acadia Healthcare in a report on Thursday, October 5th. They issued a “hold” rating for the company. Royal Bank of Canada reduced their target price on Acadia Healthcare from $99.00 to $94.00 and set an “outperform” rating for the company in a report on Tuesday, November 7th. Cantor Fitzgerald raised their target price on Acadia Healthcare from $83.00 to $85.00 and gave the company a “neutral” rating in a report on Thursday, September 14th. Finally, TheStreet downgraded Acadia Healthcare from a “b” rating to a “c” rating in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Hold” and an average target price of $84.17.
Get Our Latest Research Report on ACHC
Institutional Trading of Acadia Healthcare
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ACHC. FMR LLC increased its position in Acadia Healthcare by 117.7% during the 1st quarter. FMR LLC now owns 5,279,609 shares of the company’s stock worth $381,452,000 after purchasing an additional 2,854,393 shares in the last quarter. Hawk Ridge Capital Management LP lifted its stake in shares of Acadia Healthcare by 703.6% in the 1st quarter. Hawk Ridge Capital Management LP now owns 1,278,589 shares of the company’s stock valued at $92,378,000 after purchasing an additional 1,119,489 shares in the last quarter. Wellington Management Group LLP lifted its stake in shares of Acadia Healthcare by 17.8% in the 1st quarter. Wellington Management Group LLP now owns 5,626,846 shares of the company’s stock valued at $406,540,000 after purchasing an additional 850,056 shares in the last quarter. William Blair Investment Management LLC lifted its stake in shares of Acadia Healthcare by 19.8% in the 2nd quarter. William Blair Investment Management LLC now owns 3,048,854 shares of the company’s stock valued at $242,811,000 after purchasing an additional 504,572 shares in the last quarter. Finally, Durable Capital Partners LP lifted its stake in shares of Acadia Healthcare by 30.8% in the 4th quarter. Durable Capital Partners LP now owns 1,941,595 shares of the company’s stock valued at $159,832,000 after purchasing an additional 457,687 shares in the last quarter.
Acadia Healthcare Company Profile (Get Free Report)
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. It offers behavioral healthcare services to its patients in various settings, including inpatient psychiatric facilities, specialty treatment facilities, residential treatment centers, eating disorder facilities, and outpatient clinics.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Acadia Healthcare, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Acadia Healthcare wasn’t on the list.
While Acadia Healthcare currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
MarketBeat’s analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.